Abstracts

HIV Assembly, Maturation Inhibitors, and Drug Resistance

Presentation: HIV-1 particle assembly is driven by the viral Gag polyprotein precursor, which initiates assembly by forming an immature Gag lattice at the inner leaflet of the infected cell plasma membrane. Following completion of immature particle assembly and virus budding, the viral protease (PR) cleaves the Gag precursor at a number of sites to generate…

Syphilis Management Conundrums

Presentation: As the rates of syphilis continue to increase, clinicians are caring for patients with complex clinical presentations, and they are facing challenging management dilemmas. In this session, we will answer the following questions: How do we approach rapid plasma reagin (RPR) titers that fail to decline appropriately following therapy? RPR titers that increase following…

The Burgeoning Epidemic of Congenital Syphilis

Presentation: Congenital syphilis (CS) is transmitted from an infected mother to her unborn child during pregnancy, leading to severe health complications such as stillbirth, miscarriage, infant death, and maternal and infant morbidity. These adverse outcomes can be prevented through timely screening and treatment during antenatal care. The increasing prevalence of CS is associated with several…

Cardiometabolic Risks and Complications: Adolescents and Young Adults With Perinatally Acquired HIV

Presentation: Antiretroviral therapy (ART) scale-up has dramatically reduced rates of pediatric HIV mortality and morbidity. Children living with perinatally acquired HIV (PHIV) are living through adolescence and well into adulthood, such that adolescents now represent the largest growing population living with HIV. This presentation aims to discuss the literature describing the prevalence of cardiometabolic complications…

Epidemiology of Perinatally Acquired HIV Among Adolescents and Young Adults

Presentation: Adolescents (10–19 years) and youth (15–24 years) living with perinatally acquired HIV represent increasing proportions of people living with HIV. Improved access to antiretroviral therapy globally has resulted in children who acquire HIV around the time of birth or through breastfeeding surviving into adolescence. While many are thriving, a significant proportion face several challenges…

Germline Targeting Strategies to Get On the Road Again

Presentation: It is generally believed that an HIV-1 vaccine should induce broadly neutralizing antibodies (bNAbs), but no vaccine candidate so far has been able to do so effectively. A critical step in the generation of HIV-1 bNAbs is the activation of specific naïve B cells expressing germline antibody precursors that have the potential to evolve…